In A Nutshell College football players take hundreds of head hits each season, even without diagnosed concussions. In a small ...
The study reframes neuropathy as a key determinant of tissue recovery rather than an irreversible endpoint. BREA, Calif., Jan. 21, 2026 /PRNewswire/ -- Rapid Nexus Nanotech Wound Solutions, Inc., a ...
I first heard the word “fascia” before getting dry-needled for the first time at physical therapy. It was described to me as ...
Peptinovo Biopharma, an Ann Arbor–based biotechnology company pioneering targeted cancer therapies through its first-of-its-kind proprietary PALM™ nanotechnology, today announced it has received ...
The rags-to-riches story for the University of Wisconsin-River Falls football program has its fairy-tale ending. Once the doormat of the Wisconsin Intercollegiate Athletic Conference but now a ...
Erwin Perzy I, a surgical instruments mechanic in Vienna, was experimenting with a water-filled glass globe around 1900 to amplify light when added particles drifted down like snow. The "snowfall" ...
Finding evidence of ancient mathematics isn’t easy outside of written records, but a new study suggests that floral pottery from the Halafian culture of northern Mesopotamia shows evidence of geometry ...
“TY1 is the first exomer – a new class of drugs that address tissue damage in unexpected ways.” TY1 has the structure of existing RNA drugs, and works like its natural version – amplifying the ...
The MarketWatch News Department was not involved in the creation of this content. Zurich, Switzerland, December 03, 2025 -- MUVON Therapeutics AG, a clinical-stage biotechnology company, reports ...
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (STRO), a clinical stage oncology company pioneering site-specific and novel-format antibody drug conjugates (ADCs) ...
SOUTH SAN FRANCISCO, Calif., Dec. 03, 2025 (GLOBE NEWSWIRE) -- Sutro Biopharma, Inc. (Sutro or the Company) (NASDAQ: STRO), a clinical stage oncology company pioneering site-specific and novel-format ...